CVS Group (LON:CVSG) Share Price Crosses Above 200 Day Moving Average - Should You Sell?

Key Points

• CVS Group plc shares passed above the 200-day moving average during trading, reaching a high of GBX 1,226 ($16.49) before closing at GBX 1,214 ($16.33).
• Berenberg Bank reaffirmed a "buy" rating for CVS Group and set a target price of GBX 2,000 ($26.90) for the stock.
• Insiders David Wilton and Richard Fairman recently acquired shares of CVS Group, indicating strong confidence from internal stakeholders.

Shares of CVS Group plc (LON:CVSG - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,125.66 ($15.20) and traded as high as GBX 1,226 ($16.55). CVS Group shares last traded at GBX 1,214 ($16.39), with a volume of 46,559 shares trading hands.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 2,000 ($27.00) price target on shares of CVS Group in a research report on Thursday, July 24th.

CVS Group Price Performance

The company has a market capitalization of £884.44 million, a PE ratio of 42.72, a P/E/G ratio of 1.77 and a beta of 1.02. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09. The company's 50-day simple moving average is GBX 1,238.24 and its 200-day simple moving average is GBX 1,131.03.

Insider Activity at CVS Group

In other CVS Group news, insider Richard Fairman acquired 1,644 shares of the firm's stock in a transaction on Friday, July 11th. The stock was bought at an average cost of GBX 1,216 ($16.42) per share, for a total transaction of £19,991.04 ($26,989.39). Also, insider David Wilton purchased 1,000 shares of CVS Group stock in a transaction that occurred on Monday, June 2nd. The shares were bought at an average cost of GBX 1,248 ($16.85) per share, for a total transaction of £12,480 ($16,848.93). Insiders own 5.83% of the company's stock.

About CVS Group

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.